Fabry’s disease – Diagnostics – Overview of Information and Clinical Research

Getting the right diagnosis for Fabry disease can be life-changing, but the journey to that answer often requires specific tests and careful evaluation. Early and accurate identification of this rare genetic condition helps doctors start treatments that may prevent serious complications affecting the heart, kidneys, and other vital organs.

Introduction: When to Seek Diagnostic Testing

If you experience unexplained burning pain in your hands and feet, unusual skin rashes, or digestive problems that seem to have no clear cause, it may be time to talk to your doctor about Fabry disease. This rare genetic condition often goes undiagnosed for years because its symptoms can mimic many other illnesses. People may visit multiple doctors and receive different diagnoses before someone considers Fabry disease as a possibility.^[1]^[8]

Diagnostic testing becomes especially important if someone in your family has already been diagnosed with Fabry disease. Because this condition is inherited and passed down through families, blood relatives of affected individuals should strongly consider getting tested even if they feel perfectly healthy. The disease can cause organ damage silently, without obvious symptoms, particularly in women who may have milder or more variable presentations.^[1]^[3]

Young adults who experience strokes, heart problems, or kidney dysfunction without typical risk factors should also be evaluated for Fabry disease. These serious complications appearing at an unusually young age can be warning signs of an underlying genetic disorder. Men typically develop more severe symptoms than women, though both sexes can experience significant health problems from the condition.^[2]

Children presenting with chronic pain that is dismissed as growing pains, especially when accompanied by reduced ability to sweat, heat intolerance, or gastrointestinal issues, deserve careful evaluation. Classic Fabry disease symptoms can appear as early as age two, yet many children go years without proper diagnosis because their complaints are attributed to other causes.^[1]^[6]

⚠️ Important

Women with Fabry disease are often underdiagnosed because they may have milder symptoms or even no symptoms at all. However, they can still experience serious complications including heart disease, stroke, and kidney failure. If you are a woman with a family history of Fabry disease, do not assume you are unaffected simply because you feel well.

Classic Diagnostic Methods for Identifying Fabry Disease

The diagnostic journey for Fabry disease typically begins with a thorough physical examination and detailed discussion of your medical history and symptoms. Your doctor will want to know about any family members who have had unexplained strokes, kidney failure, or heart disease at young ages. This family history information can provide crucial clues that point toward a genetic condition.^[5]^[12]

Blood testing represents the primary diagnostic tool for confirming Fabry disease in males. This test measures the activity level of an enzyme called alpha-galactosidase A, which is the enzyme that people with Fabry disease either lack completely or have in insufficient amounts. In males with classic Fabry disease, the enzyme activity will be extremely low or absent. The blood sample is usually drawn from a vein in your arm, just like a routine blood test.^[5]^[12]

For women, the enzyme activity blood test is less reliable because females have two X chromosomes, and one may compensate for the defective gene on the other. This means a woman with Fabry disease might show normal or only slightly reduced enzyme activity in her blood, even though she carries the genetic mutation and may develop symptoms. Because of this limitation, genetic testing becomes especially important for confirming the diagnosis in females.^[3]^[6]

Genetic testing examines your DNA to look for mutations in the GLA gene, which provides instructions for making the alpha-galactosidase A enzyme. This test can identify the specific genetic change causing the disease in your family. Genetic testing is definitive for both males and females, and hundreds of different mutations in the GLA gene have been identified as causes of Fabry disease. A small blood sample or cheek swab is typically all that is needed for this analysis.^[2]^[3]

Additional imaging and diagnostic tests help doctors understand how much the disease has affected various organs in your body. An eye examination using a specialized instrument called a slit lamp can detect a characteristic pattern in the cornea called cornea verticillata. This whorl-like pattern of cream-colored lines appears in many people with Fabry disease but does not affect vision. An eye doctor or optometrist can identify this sign during a routine examination.^[1]^[4]

Heart function is evaluated through several tests. An electrocardiogram, or ECG, records the electrical signals in your heart to check for irregular heart rhythms. An echocardiogram uses sound waves to create moving pictures of your heart, allowing doctors to see if the heart muscle has become abnormally thick, a common complication of Fabry disease called hypertrophic cardiomyopathy. These tests are painless and typically performed in a doctor’s office or hospital.^[11]

Kidney function requires careful monitoring through urine and blood tests. A urine test can detect the presence of protein or blood in your urine, which are early warning signs of kidney damage. The appearance of foamy urine often indicates protein leakage, medically known as proteinuria. Blood tests measure levels of waste products that healthy kidneys normally filter out, helping determine how well your kidneys are functioning.^[1]^[5]

Brain imaging using magnetic resonance imaging, or MRI, and computed tomography, or CT scans, can reveal areas that resemble stroke conditions and help determine whether neurological damage has occurred. These imaging techniques are particularly important because people with Fabry disease have an increased risk of stroke, even at young ages. A cerebrovascular evaluation examines the blood vessels in your brain and may include an angiography, which uses contrast dye to make blood vessels visible on X-rays.^[5]^[12]

Skin examination may reveal small, dark red or purple spots called angiokeratomas, typically appearing in clusters between the belly button and knees. These raised skin lesions are common in Fabry disease and become more numerous with age. While they are not harmful themselves, their presence can be an important diagnostic clue that prompts further testing.^[1]^[4]

Hearing tests and evaluation for tinnitus, or ringing in the ears, form part of the comprehensive assessment. Fabry disease can cause hearing loss due to the narrowing of blood vessels in the inner ear. Your doctor may refer you to an audiologist for detailed hearing evaluation if you report these symptoms.^[1]

Diagnostic Testing for Clinical Trial Qualification

When researchers design clinical trials to test new treatments for Fabry disease, they must carefully select participants who meet specific criteria. These qualification standards ensure that the study results are accurate and that participants are likely to benefit from or tolerate the experimental treatment being tested. The diagnostic tests used to determine whether someone can join a clinical trial are often more extensive than those used for routine diagnosis.^[10]

Confirmation of the genetic diagnosis through molecular testing is typically required for clinical trial enrollment. Researchers need to document the exact mutation in the GLA gene that each participant carries. This genetic information helps them understand whether the experimental treatment might work for that particular type of mutation. Some treatments under development are designed to work only with certain types of genetic changes.^[2]^[10]

Baseline enzyme activity measurements are standard requirements. Researchers measure the alpha-galactosidase A activity level in your blood before any treatment begins. This baseline measurement allows them to compare whether the experimental treatment successfully increases enzyme activity. In males with classic Fabry disease, enzyme activity must typically be absent or extremely low to qualify for certain studies.^[10]^[13]

Organ function assessments determine whether your heart, kidneys, and other organs are healthy enough for you to safely participate in the study. Clinical trials often exclude people whose organ damage has progressed too far, as they may be at higher risk for complications. Conversely, some trials specifically recruit people with early organ involvement to test whether new treatments can prevent progression to severe disease.^[10]

Blood tests measuring levels of globotriaosylceramide, often abbreviated as Gb3, and its related compound lyso-Gb3 are common trial requirements. These fatty substances accumulate in the cells of people with Fabry disease. Researchers measure their levels to assess disease severity and to determine whether a treatment successfully reduces this harmful buildup.^[2]^[10]

Cardiac MRI scans provide detailed images of heart structure and can detect early signs of heart muscle thickening or scarring. Many clinical trials require these specialized imaging studies at enrollment and at regular intervals during the study. The images help researchers determine whether an experimental treatment prevents or reverses heart damage caused by Fabry disease.^[10]

Kidney biopsies may be performed in some research studies, though this is less common. During a kidney biopsy, a doctor removes a tiny piece of kidney tissue using a special needle. A pathologist then examines the tissue under a microscope to look for the characteristic accumulation of fatty substances in kidney cells. This invasive procedure carries some risk, so it is typically reserved for research situations where the information is essential.^[10]

Quality of life assessments and pain questionnaires help researchers understand how Fabry disease affects daily living. Trial participants may be asked to complete detailed surveys about their pain levels, fatigue, ability to perform daily activities, and emotional wellbeing. These assessments provide important information about whether a treatment improves not just laboratory values but also how people actually feel.^[10]

Previous treatment history must be documented for trial enrollment. Researchers need to know whether you have received enzyme replacement therapy or other specific treatments, for how long, and when you last received them. Some trials require participants to stop their current Fabry treatment for a period before joining the study, while others only accept people who have never been treated. These requirements depend on the study design and research questions being investigated.^[10]^[13]

⚠️ Important

Participating in a clinical trial requires careful consideration. While you may gain access to new treatments before they are widely available, you will also need to undergo more frequent testing and monitoring than typical patients. Discuss the potential benefits and burdens with your doctor and family before deciding whether to participate.

Age and disease stage requirements vary by trial. Some studies focus specifically on children to understand how treatments work in young patients, while others recruit only adults. Certain trials target people with early disease who have minimal organ damage, testing whether treatment can prevent complications. Other studies include people with more advanced disease to determine whether treatments can reverse existing damage.^[10]

Prognosis and Survival Rate

Prognosis

The outlook for people with Fabry disease varies considerably depending on several factors, including the type of disease, when treatment begins, and how severely different organs are affected. Fabry disease is progressive, meaning it typically gets worse over time as fatty substances continue to accumulate in cells throughout the body. Men generally experience more severe disease progression than women, though both sexes can develop life-threatening complications.^[17]

People with classic Fabry disease, where symptoms begin in childhood, usually face more serious health challenges than those with late-onset disease. Without treatment, men with classic Fabry disease often develop kidney failure, severe heart disease, or suffer strokes between ages 30 and 45. Women with Fabry disease may not experience major complications until their 50s or later, though some women do develop severe symptoms earlier in life.^[17]^[9]

Early diagnosis and treatment significantly improve the prognosis. Enzyme replacement therapy and other treatments can slow disease progression and reduce the accumulation of harmful fatty substances in organs. When treatment begins before substantial organ damage has occurred, people with Fabry disease have much better outcomes. This is why doctors often recommend starting treatment immediately upon diagnosis in males, even if they have no symptoms yet, because organ damage may already be happening silently.^[11]

The development of life-threatening complications determines long-term prognosis. Kidney disease progressing to kidney failure typically occurs in the third or fourth decade of life in untreated individuals. Heart complications including irregular heart rhythms, heart valve problems, and heart failure significantly impact prognosis. Strokes, even when people survive them, can cause lasting disability that affects quality of life. Early detection and management of these complications through regular monitoring improves outcomes.^[1]^[2]

Many people with Fabry disease now live full and productive lives thanks to available treatments and improved medical care. However, the condition remains serious, particularly for men who tend not to live as long as people without the disease. The most common causes of premature death are heart disease and kidney disease, which is why careful monitoring and treatment of these organs is so important.^[17]

Survival rate

Life expectancy for people with Fabry disease has improved dramatically with the availability of enzyme replacement therapy and better supportive care. Historically, before effective treatments existed, men with classic Fabry disease often died in their 40s or 50s, while women typically lived longer but still had reduced life expectancy compared to the general population.^[17]

Today, with proper treatment and medical management, people with Fabry disease are living longer and healthier lives than ever before. One patient advocate with classic Fabry disease who has received enzyme replacement therapy for over 20 years reached age 69, an achievement he considers both significant and unexpected given his family history where five relatives died from the disease between ages 37 and 51.^[15]

The prognosis for women with Fabry disease is generally better than for men, though this does not mean women are unaffected. Women with the genetic mutation have a significant risk of developing serious complications including heart disease, stroke, and kidney failure, though these often appear later in life than in men. Both men and women benefit from early diagnosis, regular monitoring, and appropriate treatment to maximize their life expectancy and quality of life.^[3]^[17]

#1 Clinical Trials Search in Europe